A01K 2227/105
Murine
A01K2227/105 (Murine) appears on 3,495 US grants and 7,020 published applications in this corpus.
Search patents in A01K- Granted patents
- 3,495
- Published applications
- 7,020
- Assignees
- 2,122
- Inventors
- 11,559
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 5 | 0 |
| 1993 | 2 | 0 |
| 1994 | 6 | 0 |
| 1995 | 8 | 0 |
| 1996 | 35 | 0 |
| 1997 | 61 | 0 |
| 1998 | 89 | 0 |
| 1999 | 92 | 0 |
| 2000 | 92 | 0 |
| 2001 | 101 | 20 |
| 2002 | 68 | 219 |
| 2003 | 96 | 739 |
| 2004 | 68 | 226 |
| 2005 | 58 | 255 |
| 2006 | 100 | 293 |
| 2007 | 123 | 217 |
| 2008 | 117 | 223 |
| 2009 | 106 | 206 |
| 2010 | 119 | 254 |
| 2011 | 97 | 236 |
| 2012 | 106 | 173 |
| 2013 | 100 | 187 |
| 2014 | 104 | 177 |
| 2015 | 128 | 219 |
| 2016 | 117 | 230 |
| 2017 | 135 | 229 |
| 2018 | 127 | 236 |
| 2019 | 133 | 305 |
| 2020 | 146 | 368 |
| 2021 | 141 | 365 |
| 2022 | 144 | 410 |
| 2023 | 166 | 364 |
| 2024 | 172 | 356 |
| 2025 | 190 | 325 |
| 2026 | 139 | 188 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Non-human animals having humanized Fc-gamma receptors29 Sep 2026US 12,745,761 B2Regeneron Pharmaceuticals, Inc.
- Genetically modified non-human animal with human or chimeric TFR122 Sep 2026US 12,740,550 B2Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
- Methods of treating rheumatoid arthritis using RNA-guided genome editing of HLA gene22 Sep 2026US 12,742,179 B2National Jewish Health
- Non-canonical SWI/SNF complex and uses thereof8 Sep 2026US 12,729,225 B2Dana-Farber Cancer Institute, Inc.
- Rat models for CMT2A that develop a progressive neuropathy1 Sep 2026US 12,721,327 B2Charcot-Marie-Tooth Association
- Humanized ace2-expressing transgenic mouse susceptible to sars-cov-2 virus infection and method for producing same8 Oct 2026US 2026/0305587 A1Seoul National University R&Db Foundation
- Genetically Modified Non-Human Animals and Methods of Use Thereof8 Oct 2026US 2026/0305588 A1Institute for Research in Biomedicine (IRB)
- Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse8 Oct 2026US 2026/0308532 A1Fred Hutchinson Cancer Center
- Mouse model with humanized telomere1 Oct 2026US 2026/0293864 A1Washington State Univesity
- Non-human animal, kit, and method for producing replacement organ24 Sep 2026US 2026/0283124 A1The Jikei University
Most cited
By later US patents
- Ransgenic non-human animals for producing heterologous antibodies1,941US 5,545,806 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies of various isotypes1,748US 5,569,825 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies1,680US 5,633,425 AGenPharm International, Inc. · 1997
- Transgenic non-human animals for producing heterologous antibodies1,604US 5,625,126 AGenPharm International, Inc. · 1997
- Production of antibodies from transgenic animals1,567US 5,545,807 AMedical Research Council · 1996